Cuello and Sofroniev concluded that AD is secondarily produced by retrograde atrophy of cholinergic neurons from the basal nucleus, which can be treated by applying Nerve Growth Factor (NGF) [24], with the maintenance of the “cholinergic tone” [25,26]. This evidence concerns the gene NGF and Alzheimer disease.